What Does NxGen MDx Screen For?


What Does NxGen MDx Screen For?

Retinitis Pigmentosa 59

What Your Test Results Mean:

Carriers typically show no symptoms of retinitis pigmentosa 59; however, carriers are at an increased risk of having a child with retinitis pigmentosa 59. Risk for the current or future pregnancies is dependent on your partner’s carrier status. Carrier testing of your partner is recommended in addition to consultation with a genetic counselor for more detailed risk assessment.

Disease Explained:

Retinitis pigmentosa 59 is an inherited condition that characterized by progressive vision loss. Affected individuals usually have normal vision in infancy and childhood, but are diagnosed with retinitis pigmentosa in their teenage years due to impaired night and peripheral vision. The photoreceptors on the retina continue to degenerate over time, and individuals eventually lose most or all of their vision and are declared legally blind by their thirties or forties. There is no cure for retinitis pigmentosa, but nutritional supplements such as vitamin A can help slow the progression of the disease, and researchers are working on experimental treatments such as retinal transplants and implants and drug therapy.

How the Genetics Works:

Retinitis pigmentosa 59 is an autosomal recessive disorder caused by pathogenic variants in the DHDDS gene. In general, individuals have two copies of the DHDDS gene. Carriers of retinitis pigmentosa 59 have a single variant in one copy of the DHDDS gene while individuals with retinitis pigmentosa 59 have variants in both copies of their genes, one inherited from each parent. Risk for two carriers to have a child with the disorder is 25%.

Which Screens Are Right for You?


Planning to Have a Baby Already Expecting
Which Screens Are Right for You?

Talk to a Genetic Counselor


Discuss Your Screening Results